A drug designed to treat a disease unique to Iceland is reportedly close to completion, Viðskiptablaðið reported today. The development marks a significant step towards addressing a medical condition that is largely confined to the country.
According to the report, researchers and developers have worked on the drug for a decade. The extended effort underlines the complexity of developing treatments for rare and geographically specific disorders.
The disease is not only a concern in its own right but is also reportedly linked to other hereditary illnesses and to Alzheimer’s disease, Viðskiptablaðið reported.
Sources
- Viðskiptablaðið (first reported) in Icelandic
